Prévisions du marché européen du diagnostic moléculaire au point de service jusqu’en 2028 – Impact du COVID-19 et analyse régionale par produits et services (tests et kits, instruments, services et logiciels), technologie (PCR, technologie d’amplification isotherme des acides nucléiques (INAAT), et autres technologies), application (maladies infectieuses, oncologie, hématologie, tests prénatals, endocrinologie et autres applications), utilisateur final (hôpitaux et cliniques, laboratoires de diagnostic, instituts de recherche et universitaires et autres)

Introduction au marché

Les diagnostics moléculaires au point d\'intervention comprennent des appareils portables et des tests et ; kits utilisés pour détecter et diagnostiquer des maladies dans des échantillons humains, tels que des prélèvements de gorge, du sang, du sérum et des selles. Les diagnostics moléculaires passent des laboratoires centralisés aux tests moléculaires décentralisés sur les lieux d\'intervention. En raison de sa simplicité, de sa commodité, de son délai d\'exécution rapide et de son potentiel d\'amélioration des résultats pour les patients, le POCT gagne rapidement du terrain.

De plus, la demande croissante de méthodes de détection virale spécifiques qui consomment on s\'attend à ce que moins de temps pour contrôler les infections en temps opportun soutienne la croissance du marché au cours de la période de prévision.

En Europe, actuellement, le Royaume-Uni et la Russie sont les pays les plus durement touchés par le COVID. -19, suivie par la France, l\'Espagne, l\'Italie et l\'Allemagne. La mise en œuvre de mesures drastiques et de restrictions de voyage, notamment la fermeture des frontières, a eu un impact sur l\'importation et l\'exportation de produits, en particulier au premier semestre 2020. La propagation continue de la maladie a entraîné une demande accrue de solutions de diagnostic avancées en Europe, ce qui stimuler l’adoption de kits de diagnostic moléculaire sur le lieu d’intervention. De plus, les investissements et les activités commerciales ininterrompus des acteurs de l’industrie stimulent également la croissance du marché du diagnostic moléculaire au point d’intervention. En 2020, l’Agence européenne des médicaments (EMA) a approuvé l’autorisation de mise sur le marché d’environ 97 médicaments, dont 39 étaient des médicaments nouveaux. En octobre 2020, Eurofins a introduit sur le marché européen des tests de diagnostic du COVID-19 basés sur la PCR avec des options d\'auto-échantillonnage à domicile. En janvier 2020, la Commission de l\'Union européenne (UE) a annoncé un appel d\'urgence, par lequel elle a accordé 55,64 millions de dollars américains à 18 projets de recherche. Parmi ceux-ci, 3 de ces projets reçoivent un total de 7,39 millions de dollars US pour développer des diagnostics efficaces et rapides sur les lieux d\'intervention.

Aperçu du marché and Dynamics

Le marché européen des diagnostics moléculaires au point d\'intervention devrait atteindre 1 524,4 millions de dollars américains d\'ici 2028, contre 653,5 millions de dollars américains en 2028. 2021. On estime que le marché connaîtra une croissance à un TCAC de 12,9 % entre 2021 et 2028. L’essor des gadgets électroniques grand public connectés a transformé des secteurs entiers de l’économie, y compris la santé. Les patients et les consommateurs ajustent leurs interactions avec les produits médicaux et les produits POC. services en raison de la pénétration des appareils mobiles. De plus, avec l’essor des gadgets connectés, les consommateurs transforment la façon dont ils gèrent et prennent le contrôle de leur santé. Par conséquent, les fabricants développent des dispositifs de diagnostic moléculaire POC faciles à utiliser, pratiques et abordables pour les environnements hors laboratoire afin de répondre à la demande croissante des consommateurs. Les dispositifs de diagnostic et de surveillance moléculaires POC devraient devenir monnaie courante à l\'avenir dans les environnements résidentiels des économies à revenu faible et intermédiaire en raison de l\'émergence rapide du paysage technologique et de la pénétration croissante des smartphones et des appareils connectés.

Segments clés du marché

En termes de produits et de produits. services, le segment des tests et des kits représentait la plus grande part du marché européen du diagnostic moléculaire au point de service en 2020. En termes de technologie, le segment PCR représentait la plus grande part du marché européen du diagnostic moléculaire au point de service. en 2020. En termes d’application, le segment des maladies infectieuses représentait la plus grande part du marché européen du diagnostic moléculaire au point de service en 2020. En termes d’utilisateur final, le segment des laboratoires de diagnostic représentait la plus grande part du marché européen du diagnostic moléculaire au point de service. Marché des diagnostics moléculaires de soins en 2020.

Principales sources et entreprises répertoriées

Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché du diagnostic moléculaire au point de service en Europe sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents gouvernementaux nationaux et les bases de données statistiques. entre autres. Les principales sociétés répertoriées dans le rapport sont bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation et Bio-Rad Laboratories, Inc.

Rapport sur les raisons d\'acheter

Comprendre le paysage du marché européen du diagnostic moléculaire au point de service et identifier les segments de marché susceptibles de garantir un rendement élevé
Pour comprendre le paysage du marché en constante évolution et garder une longueur d\'avance sur la concurrence
Pour planifier efficacement les fusions et acquisitions et les accords de partenariat dans le point Europe -of-Care Molecular Diagnostics marché en identifiant les segments avec les ventes probables les plus prometteuses
Prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète des performances du marché de divers segments
Pour obtenir les prévisions de revenus du marché européen du diagnostic moléculaire au point de service en fonction de divers segments pour la période 2021-2028

< p>SEGMENTATION DU MARCHÉ DU DIAGNOSTIC MOLÉCULAIRE AU POINT DE SOINS EN EUROPE

Par Produit et amp; Services

Tests et kits
Instruments
Services et logiciels

Par technologie

PCR
Technologie d\'amplification isotherme des acides nucléiques (INAAT)
Autres technologies

Par Application

Par utilisateur final

Hôpitaux et cliniques
Diagnostic Laboratoires
Instituts de recherche et universitaires
Autres

< span>Par pays

Europe

• Allemagne

• Royaume-Uni

• France

• Espagne

• Italie

• Reste de l\'Europe

Entreprises mentionnées

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2 Europe Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3 Europe Point-of-Care Molecular Diagnostics Market – By Application

1.3.4 Europe Point-of-Care Molecular Diagnostics Market – By End User

1.3.5 Europe Point-of-Care Molecular Diagnostics Market– By Geography

2. Europe Point-of-Care Molecular Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe – PEST Analysis

4.3 Experts Opinion

5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 Pricing Pressures owing to Reimbursement Cuts

5.3 Market Opportunities

5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4 Future Trends

5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5 Impact Analysis

6. Point-of-Care Molecular Diagnostics Market– Europe Analysis

6.1 Europe Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1 Overview

7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3 Assays and Kits

7.3.1 Overview

7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Services and Software

7.5.1 Overview

7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1 Overview

8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3 PCR

8.3.1 Overview

8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1 Overview

8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1 Overview

9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3 Infectious Disease

9.3.1 Overview

9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hematology

9.5.1 Overview

9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Prenatal Testing

9.6.1 Overview

9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Endocrinology

9.7.1 Overview

9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1 Overview

10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Diagnostic Laboratories

10.4.1 Overview

10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Research and Academic Institutes

10.5.1 Overview

10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11. Europe Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1 Europe: Point-of-Care Molecular Diagnostics Market

11.1.1 Overview

11.1.2 Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3 Europe: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

11.1.4 Europe: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

11.1.5 Europe: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

11.1.6 Europe: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

11.1.7 Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

11.1.7.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2 UK: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.1.3 UK: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.1.4 UK: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.1.5 UK: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.2 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2 Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.2.3 Germany: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.2.4 Germany: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.2.5 Germany: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.3 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2 France: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.3.3 France: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.3.4 France: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.3.5 France: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.4 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.1 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.2 Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.4.3 Italy: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.4.4 Italy: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.4.5 Italy: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.5 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.1 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.2 Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.5.3 Spain: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.5.4 Spain: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.5.5 Spain: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.6 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.1 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.2 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.6.3 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.6.4 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.6.5 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 bioMérieux SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Abbott

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERIDIAN BIOSCIENCE, INC.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Enzo Biochem Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Biocartis

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Quidel Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Danaher

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 BIO-RAD LABORATORIES INC.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 binx health, inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 2. Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028(US$ Million)

Table 4. Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 5. UK: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 6. UK: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 7. UK: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. UK: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 9. Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 10. Germany: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 11. Germany: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 13. France: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 14. France: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 15. France: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 16. France: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 19. Italy: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Italy: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 22. Spain: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 23. Spain: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 24. Spain: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 25. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 26. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 27. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 28. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 29. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 30. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 31. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES

Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2. Europe Point-of-Care Molecular Diagnostics Market Overview

Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in Europe Point-of-Care Molecular Diagnostics Market

Figure 4. UK to Show Significant Growth During Forecast Period

Figure 5. Europe Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6. Europe PEST Analysis

Figure 7. Europe Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

Figure 29. Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 30. Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

Figure 31. UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 32. Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 33. France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 34. Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 35. Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 36. Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 37. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Europe

Figure 38. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Point-of-Care molecular diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Europe Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000